Concepedia

Jonathan A. Covel

JA

Statistics

Publications

11

Citations

580

H-Index

11

Active since

1995

Affiliations

Amplyx Pharmaceuticals (United States)(Current)

University of Utah

Arena Pharmaceuticals (United States)

Jonathan A. Covel is an author at Amplyx Pharmaceuticals (United States) specializing in pharmacology, drug discovery, and medicine.

Top concepts

Publications per year

1995–2019

11

Publications

11

Total Synthesis of Bryostatin 1

Gary E. Keck, Yam B. Poudel, Thomas J. Cummins et al. · Journal of the American Chemical Society · 2010 · 152 citations

, , +13

<i>In Vitro</i> and <i>In Vivo</i> Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus

Karen Joy Shaw, Wiley A. Schell, Jonathan A. Covel et al. · Antimicrobial Agents and Chemotherapy · 2018 · 113 citations · Full text

Pyran Annulation:  Asymmetric Synthesis of 2,6-Disubstituted-4-methylene Tetrahydropyrans

Gary E. Keck, Jonathan A. Covel, Tobias Schiff et al. · Organic Letters · 2002 · 86 citations · Full text

APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental <i>Coccidioides immitis</i> Pneumonia

Suganya Viriyakosol, Mili Kapoor, Sharon Okamoto et al. · Antimicrobial Agents and Chemotherapy · 2018 · 51 citations · Full text

Asymmetric Total Synthesis of Rhizoxin D Financial support has been provided by the National Institutes of Health (through grant GM-28961) and by Pfizer, Inc.

Gary E. Keck, Carrie A. Wager, Travis T. Wager et al. · PubMed · 2001 · 39 citations

, , +25

1–5 of 11